Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yuma Yamada(Hokkaido University), Hideyoshi Harashima(Hokkaido University), Satrialdi Satrialdi(Bandung Institute of Technology), Jiro Abe(Hokkaido University), Mitsue Hibino(Hokkaido University), Daisuke Sasaki(TUM Klinikum)
Cited by 123
Related Papers
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
|Biological and Pharmaceutical Bulletin|2013|479
Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
|Advanced Drug Delivery Reviews|2008|254
Challenges in Promoting Mitochondrial Transplantation Therapy
|International Journal of Molecular Sciences|2020|106
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver
|Journal of Controlled Release|2015|97